RightEye Enters Into Agreement With MIT to Research Ocular Biomarker ‘Signature’ for Lyme Disease
CDC Reports Lyme Disease Cases Tripling. Current Testing Methods Have Significant Shortcomings BETHESDA, Md., April 25, 2022 (Newswire.com) – RightEye, the world’s leading eye-tracking biomarker company, has signed a research collaboration agreement…